SAN MATEO, Calif., April 7, 2025 /PRNewswire/ -- Cala, the bioelectronic medicine leader, who recently raised an oversubscribed growth financing round...
CHICAGO, April 4, 2025 /PRNewswire/ -- In a historic moment, BlackDoctor.org (BDO) inducts its first class into the inaugural TBH...
Three epilepsy posters to be presented in scientific sessions at the American Academy of Neurology meetingLong-term 36-month data from the...
KENNEWICK, Wash., April 3, 2025 /PRNewswire/ -- Cadwell Industries, Inc., a global leader in neurodiagnostic, neuromonitoring and sleep solutions, launched its...
Academic research teams of selected projects participate in a translational research program that eliminates barriers that prevent promising discoveries from...
Three-year data from NeuroPace’s Post-Approval Study of the RNS® System in drug-resistant focal epilepsy to be shared in oral presentationMOUNTAIN...
MELBOURNE, Australia and SAN FRANCISCO, April 03, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the...
HOPCo senior leaders to present on benefits of value-based care for providers PHOENIX, April 1, 2025 /PRNewswire/ -- Healthcare Outcomes...
GE HealthCare has completed its acquisition of Sumitomo Chemical’s 50% stake in Nihon Medi-Physics (NMP), giving it full ownership. As...
NeuroQuiet Reviews NeuroQuiet VANCOUVER, WA, March 29, 2025 (GLOBE NEWSWIRE) -- NeuroQuiet Reviews In a market flooded with hearing supplements...
BOSTON, March 25, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for...
DUBLIN, March 25, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform...
NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology...
Providing the largest and most comprehensive, high sensitivity, protein biomarker analysis to advance pre-clinical research FREMONT, Calif., March 24, 2025...
BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights...
Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of...
Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise with key data readouts expected in 2025 ORX750 Phase...
Company Appoints Medical Device and Healthcare Industry Veteran with 20 Years of ExperienceEXTON, Pa., March 24, 2025 (GLOBE NEWSWIRE) --...
Innovative platform eliminates endless scrolling and care dead-ends with smart triage, personalized care matching, and real-time provider availability DALLAS, March...
DELRAY BEACH, Fla., March 20, 2025 /PRNewswire/ -- The global US Remote Patient Monitoring Market, valued at US$14.15 billion in...